Search results for
Clopidogrel is an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease and such arterial or vascular associated disorders. The pharmacokinetics study of Clopidogrel active metabolite and its antiplatelet effects are measured by ex vivo platelet aggregation assays.
Journals Related to Clopidogrel Pharmacokinetics:
Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Physiobiochemical Metabolism, Journal of Pharmacokinetics and Pharmacodynamics, Journal of Drug metabolism & Toxicology, Journal of Drug metabolism & Toxicology.